March 17, 2026

Belite Bio, Inc (BLTE) Stock Analysis: A Biotech Gem with a 27.89% Potential Upside

Belite Bio, Inc (BLTE), a dynamic player in the biotechnology sector, stands out as a promising investment opportunity, particularly for those interested in the cutting-edge field..

Currencies reprice as rate cut expectations shift across major economies

Currency markets are becoming more reactive, increasing the importance of timing and risk management for investors...

NovoCure Limited (NVCR) Stock Analysis: Exploring a Potential 109% Upside with Innovative Cancer Treatment Solutions

NovoCure Limited (NASDAQ: NVCR), a pioneering force in the medical device sector, is captivating investor attention with its innovative tumor treating fields (TTFields) technology. This Switzerland-based..

Addus HomeCare Corporation (ADUS) Stock Analysis: Unveiling a 38.92% Potential Upside Opportunity

Investors seeking opportunities in the healthcare sector should take a closer look at Addus HomeCare Corporation (NASDAQ: ADUS), a prominent player in the medical care facilities..

LifeStance Health Group, Inc. (LFST) Stock Analysis: Discover a 52.45% Potential Upside with Robust Revenue Growth

LifeStance Health Group, Inc. (NASDAQ: LFST) is setting a distinct tone in the healthcare sector, particularly within the medical care facilities industry, with its innovative approach..

LivaNova PLC (LIVN) Stock Analysis: Potential 30% Upside Amid Strong Buy Ratings

LivaNova PLC (NASDAQ: LIVN), a prominent player in the healthcare sector specializing in medical devices, is capturing the attention of investors with its robust 30.08% potential..

Privia Health Group, Inc. (PRVA) Investor Outlook: A Promising 45% Upside with Strong Buy Ratings

Privia Health Group, Inc. (NASDAQ: PRVA) is making waves in the healthcare sector, particularly within the health information services industry. With a market capitalization of $2.72..

Xenon Pharmaceuticals Inc. (XENE) Stock Analysis: Analyst Consensus Points to a Promising 42.66% Upside

Xenon Pharmaceuticals Inc. (NASDAQ: XENE), a Canadian biotechnology company specializing in neuroscience, has captured investor attention with its robust pipeline and impressive analyst ratings. As a..

BioCryst Pharmaceuticals, Inc. (BCRX) Stock Analysis: Exploring a 129% Potential Upside in the Healthcare Sector

BioCryst Pharmaceuticals, Inc. (NASDAQ: BCRX) is attracting significant attention within the healthcare sector, particularly among those invested in the dynamic world of biotechnology. With a market..

Catalyst Pharmaceuticals, Inc. (CPRX) Stock Analysis: A Biotech Gem with a 45.92% Upside Potential

Catalyst Pharmaceuticals, Inc. (NASDAQ: CPRX) stands out as a compelling investment opportunity within the biotechnology sector, attracting attention with its robust growth prospects and significant potential..

Envista Holdings Corporation (NVST): Investor Outlook on a 13.76% Potential Upside

Envista Holdings Corporation (NYSE: NVST) stands out in the healthcare sector, specifically in the medical instruments and supplies industry. With a market capitalization of $4.11 billion,..

Viking Therapeutics, Inc. (VKTX)

⚠️ No article content returned.

..

MoonLake Immunotherapeutics (MLTX) Stock Analysis: A Biotech Contender with 42.60% Upside Potential

MoonLake Immunotherapeutics, trading under the stock symbol MLTX, is emerging as a notable player in the biotechnology industry. Headquartered in Zug, Switzerland, this clinical-stage biotech company..

Sotera Health Company (SHC) Stock Analysis: Unpacking a 52.91% Potential Upside for Investors

Sotera Health Company (NASDAQ: SHC) stands as a compelling opportunity in the healthcare sector, particularly for investors seeking growth in the Diagnostics & Research industry. With..

Emerging markets edge forward as oil risks shape investor calculus

Emerging market stocks are edging higher, but oil risks and geopolitical tensions are keeping investors cautious and selective...

Improving risk appetite lifts Chinese equities

A shift in global sentiment is prompting investors to cautiously increase exposure to Chinese equities as near-term risks ease...

Asian equities advance as oil eases inflation pressure

Asian equities are rising on lower oil prices, with investors positioning ahead of central bank decisions...

RECI reports positive momentum with NAV increase to 141.5p

As at 28 February 2026, RECI maintained a diversified £284.7m portfolio with 28.9% leverage and £14.3m cash. NAV rose modestly from 140.8p to 141.5p, driven primarily..

Trustpilot delivers strong FY25 growth with expanding margins and AI momentum

Trustpilot posted 18% constant-currency bookings growth and a 4.2ppt margin improvement in 2025, supported by enterprise expansion and rising exposure in AI-driven search. The company expects..

Wickes Group delivers strong FY2025 performance and expands growth plans

Wickes reported 5.9% revenue growth to £1.64bn and a 14.4% rise in adjusted profit before tax, driven by strong retail volumes and continued momentum in Design..
Search

Funds

March 17, 2026

Currencies reprice as rate cut expectations shift across major economies

Currency markets are becoming more reactive, increasing the importance of timing and risk management for investors...

Emerging markets edge forward as oil risks shape investor calculus

Emerging market stocks are edging higher, but oil risks and geopolitical tensions are keeping investors cautious and selective...

Improving risk appetite lifts Chinese equities

A shift in global sentiment is prompting investors to cautiously increase exposure to Chinese equities as near-term risks ease...

Asian equities advance as oil eases inflation pressure

Asian equities are rising on lower oil prices, with investors positioning ahead of central bank decisions...

RECI reports positive momentum with NAV increase to 141.5p

As at 28 February 2026, RECI maintained a diversified £284.7m portfolio with 28.9% leverage and £14.3m cash. NAV rose modestly from 140.8p to 141.5p, driven primarily by interest income, with no significant valuation movements...

Trustpilot delivers strong FY25 growth with expanding margins and AI momentum

Trustpilot posted 18% constant-currency bookings growth and a 4.2ppt margin improvement in 2025, supported by enterprise expansion and rising exposure in AI-driven search. The company expects continued high-teens revenue growth in 2026...

Wickes Group delivers strong FY2025 performance and expands growth plans

Wickes reported 5.9% revenue growth to £1.64bn and a 14.4% rise in adjusted profit before tax, driven by strong retail volumes and continued momentum in Design & Installation...
Search

Funds

March 17, 2026

FTSE 100

Funds